Zevra Therapeutics (ZVRA) Notes Payables (2014 - 2020)
Zevra Therapeutics (ZVRA) posted Notes Payables of $65.9 million for Q3 2020, down 2.01% on a QoQ basis from $67.3 million in Q2 2020, and up 881.24% year-over-year from $6.7 million in Q4 2019.
Zevra Therapeutics (ZVRA) Notes Payables (2014 - 2020) Analysis & Trends
Zevra Therapeutics' Notes Payables history runs 7 years deep, the most recent figure standing at $65.9 million for Q3 2020.
- Quarterly Notes Payables rose 881.24% year-over-year to $65.9 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $65.9 million (up 881.24% YoY) and the FY2019 annual result came in at $7.0 million, up 109.45% from the prior year.
- Notes Payables was $65.9 million for Q3 2020 at Zevra Therapeutics, down from $67.3 million in the prior quarter.
- Across five years, Notes Payables topped out at $68.6 million in Q1 2020 and bottomed at $1.6 million in Q1 2016.
- A 5-year average of $17.8 million and a median of $4.9 million in 2017 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2018 — Notes Payables changed 0.0% — and 2020, when it jumped 977.02%.
- Zevra Therapeutics' Notes Payables stood at $1.9 million in 2016, then surged by 72.52% to $3.3 million in 2017, then changed by 0.0% to $3.3 million in 2018, then jumped by 109.45% to $7.0 million in 2019, then jumped by 844.3% to $65.9 million in 2020.
- Business Quant data shows ZVRA's Notes Payables at $65.9 million in Q3 2020, $67.3 million in Q2 2020, and $68.6 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 65.92 Mn |
| Jun 30, 2020 | 67.27 Mn |
| Mar 31, 2020 | 68.61 Mn |
| Dec 31, 2019 | 6.98 Mn |
| Sep 30, 2019 | 6.72 Mn |
| Jun 30, 2019 | 6.50 Mn |
| Mar 31, 2019 | 6.37 Mn |
| Dec 31, 2018 | 3.33 Mn |
| Sep 30, 2018 | 3.33 Mn |
| Jun 30, 2018 | 3.33 Mn |
| Mar 31, 2018 | 3.33 Mn |
| Dec 31, 2017 | 3.33 Mn |
| Jun 30, 2016 | 1.93 Mn |
| Mar 31, 2016 | 1.65 Mn |
| Dec 31, 2015 | 1.37 Mn |
| Sep 30, 2015 | 1.10 Mn |
| Dec 31, 2014 | 325,000.00 |